PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
November 10, 2006Risk AnalysisOpen Access

Retrospective Cost‐Effectiveness Analyses for Polio Vaccination in the United States

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Is polio vaccination cost-effective in the United States over a 50-year period?

Population

United States population over a 50-year period (1955-2005) and projected to 2015

Comparison

Polio vaccination strategies vs No vaccination

Design

Other

Follow-up

50 years (1955-2005) and projected to 2015

Authors

KTKimberly M. ThompsonRTRadboud J. Duintjer Tebbens

Discussion

Loading...

Member takes

Overview

Affirms historical net benefits of US polio vaccination; leaves open applicability to contemporary programs.

Structured PICO

Is polio vaccination cost-effective in the United States over a 50-year period?

P
Population
United States population over a 50-year period (1955-2005) and projected to 2015
I
Intervention
Polio vaccination strategies (including inactivated poliovirus vaccine)
C
Comparator
No vaccination (implied by estimation of prevented cases and deaths)
O
Outcome
Cost-effectiveness ratios and net benefits of polio vaccination

The historical US investment in polio vaccination represents a highly valuable, cost-saving public health program with net benefits of approximately $180 billion.

Cite This Study

Thompson et al. (2006) studied this question.

synapsesocial.com/papers/6a1040ae8090e499da60d900https://doi.org/10.1111/j.1539-6924.2006.00831.x
View Full Paper
Ask AI
Bookmark
Share